Hebei Shengxue Dacheng Pharmaceutical Co., Ltd.

Hebei Shengxue Dacheng Pharmaceutical Co., LTD., founded in 1997, is a modern pharmaceutical enterprise under CNNC (China National Nuclear Corporation)., we are located in Luancheng District, Shijiazhuang City. After more than 20 years of development, there are two wholly owned subsidiaries - Hebei Shengxue Dacheng Pharmaceutical (Tangshan) Co., LTD., Hebei Hongcheng Yaxin Technology Co., Ltd., and an entrusted management company - Inner Mongolia Shengxue Dacheng Pharmaceutical Co., LTD. We company has four production bases, with a total area of 1080 acres. Leading products are CTC Premix, Oxytetracycline HCL, Oxytetracycline, Streptomycin Sulfate, Dihydrostreptomycin sulfate, Colistin Sulphate, Spectinomycin, Colistimethate Sodium, Polymyxin B Sulfate, Nisin, Natamycin，Pet drugs，VB2、Colistin sulphate premix，Monensin Sodium Premix, etc. The production scale ranks the forefront in the industry. The total production capacity of various products exceeds 10,000 tons. The products sell well in China, and are exported to Europe, America, Southeast Asia, the Middle East, India, North Africa, South America and other markets. We have established long-term cooperative relations with multinational pharmaceutical leaders such as Pfizer, Zoetis, Abbott and Cargill. The company is a national high-tech enterprise, a special small and medium-sized enterprise in Hebei Province, a strategic emerging industry enterprise in Hebei Province, a post-doctoral innovation practice base in Hebei Province, a technical innovation center for veterinary drug APIs in Hebei Province, an enterprise technology center in Hebei Province and Shijiazhuang City, and an innovative enterprise in Shijiazhuang City, and has been identified as the first batch of industrial enterprises in Hebei Province.